A U.S. advisory row dealt a blow to Roche Holding AG's multibillion-dollar cancer drug Avastin on Tuesday, propelling U.S. officials to devaluate the medicine's capitulation for breast cancer....
Health News
Although a sovereign advisory cabinet endorsed stability sales of Avandia, the opinion could still be a harmful blow to the uneasy antidiabetes medication...
Health News
Although a sovereign advisory cabinet endorsed stability sales of Avandia, the opinion could still be a harmful blow to the uneasy antidiabetes medication...